For diabetic nephropathy, it has been shown that rapamycin or resveratrol inhibits mesangial cells (MCs) senescence induced by high glucose through increasing the SIRT1 expression and activity, which was completely blocked by treatment with siRNA‐SIRT1.100. This evidence concerns the gene SIRT1 and diabetic kidney disease.